leisure time -WSS

leisure time

author：entertainment 2025-09-27 09:38:06 - browse：2

Light micrograph of a fatty liver — Large vacuoles of triglyceride fat, accumulated inside liver cells. Adobe

SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks approved treatments.

Among 98 patients with nonalcoholic fatty liver disease, those on the highest dose tested of the drug, retatrutide, experienced an 86% decrease in liver fat over 48 weeks, with most of the reduction occurring early on in treatment, according to data presented here at the American Diabetes Association conference Monday.

Additionally, 93% of people on the highest dose achieved resolution of fatty liver disease, defined as having 5% or less liver fat.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： Use wet bulb globe temperature, not heat index, to protect workers

leisure time

WSS

Bird flu makes raw milk dangerous to consume, mouse study finds

Should insurance cover cosmetic surgery?

Beyond aggravation: Constipation is an American epidemic

Why we need mandatory labeling of GMO products

Researchers on aging grapple with how to calculate biological age

Hospitals need to get ahead of regulations on climate change

explore

leisure time

hotspot

In Memoriam: Notable people who died in 2023

Why we need mandatory labeling of GMO products

How to save PrEP access — and even expand it

Should insurance cover cosmetic surgery?

23andMe had bad news about my health. I wish a person had delivered it

Congress: Prevent baby formula shortages by passing a new bill

Affirmative action in medical school literally saved lives

Lawsuit challenges CMS nursing home minimum staffing rule

DIEP, the 'gold standard' of breast reconstruction, is under threat

Elevance, private equity launch primary care company

hotspot

Shionogi licenses Pompe disease therapy from Maze Therapeutics

H5N1 communication has been strictly for the birds

H5N1 communication has been strictly for the birds

Hospitals need to get ahead of regulations on climate change

The Bio Revolution is changing business and society

H5N1 bird flu: what we're starting to learn about infection in cows

hotspot

leisure time

explore

focus